妇儿健康导刊2025，Vol.4Issue(8)：107-110,4.DOI:10.3969/j.issn.2097-115X.2025.08.022
雾化吸入重组人干扰素α1b治疗儿童呼吸道腺病毒感染的临床效果
Clinical effect of aerosol inhalation of Recombinant Human Interferon α1b in the treatment of respiratory adenovirus infection in children
解霞1
作者信息
- 1. 扬州大学医学院附属扬州妇幼保健院儿科,江苏 扬州 225000
- 折叠
摘要
Abstract
Objective To observe the clinical effect of aerosol inhalation of Recombinant Human Interferon α1b in the treatment of respiratory adenovirus(Ad)infection in children.Methods Sixty children with respiratory Ad infection in Yangzhou Maternal and Child Health Care Hospital Affiliated to Yangzhou University from January to December 2023 were selected and divided into the study group(n=30)and the control group(n=30)using the random number table method.The control group received basic medication treatment,and the study group added treatment with aerosol inhalation of Recombinant Human Interferon α1b.The application effects of the two groups were compared.Results The treatment effect and total effective rate of the study group(96.67%)were higher than those of the control group(76.67%)(P<0.05).The symptom improvement time of the study group was shorter than that of the control group(P<0.05).The immune function indicators in the study group were better than those in the control group(P<0.05).There was no statistically significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion The effect of aerosol inhalation Recombinant Human Interferon α1b in the treatment of children with respiratory Ad infection is effective,which can shorten the time of symptom disappearance,improve immune function,and has clinical reference value.关键词
雾化吸入/重组人干扰素α1b/儿童呼吸道腺病毒感染/免疫功能/不良反应Key words
Aerosol inhalation/Recombinant Human Interferon α1b/Respiratory adenovirus infection in children/Immune function/Adverse reaction分类
临床医学引用本文复制引用
解霞..雾化吸入重组人干扰素α1b治疗儿童呼吸道腺病毒感染的临床效果[J].妇儿健康导刊,2025,4(8):107-110,4.
